# Thiotepa Incorporating TBI/Cy Conditioning Regimen for EBV-HLH With Central Nervous System Involvement

> **NCT05854225** · NA · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 20 (estimated)

## Conditions studied

- HLH

## Interventions

- **DRUG:** Thiotepa

## Key facts

- **NCT ID:** NCT05854225
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2024-06
- **Final completion:** 2025-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05854225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05854225, "Thiotepa Incorporating TBI/Cy Conditioning Regimen for EBV-HLH With Central Nervous System Involvement". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05854225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*